EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice

Michał Ząbczyk iD, Robert A S Ariëns iD, Anetta Undas iD

Cardiovascular Research · 17.03.2023 · 119 (1) · 94-111

DOI: 10.1093/cvr/cvad017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 20.01.2023. Verfasst von Michał Ząbczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thromboembolic Disorders Department, Institute of Cardiology, Jagiellonian University Medical College, 80 Pradnicka St, 31-202 Krakow, Poland. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Brain Ischemia, Stroke, Thrombosis. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Jagiellonian University Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrinogen conversion into insoluble fibrin and the formation of a stable clot is the final step of the coagulation cascade. Fibrin clot porosity and its susceptibility to plasmin-mediated lysis are the key fibrin measures, describing the properties of clots prepared ex vivo from citrated plasma. Cardiovascular disease (CVD), referring to coronary heart disease, heart failure, stroke, and hypertension, has been shown to be associated with the formation of dense fibrin networks that are relatively resistant to lysis. Denser fibrin mesh characterized acute patients at the onset of myocardial infarction or ischaemic stroke, while hypofibrinolysis has been identified as a persistent fibrin feature in patients following thrombotic events or in those with stable coronary artery disease. Traditional cardiovascular risk factors, such as smoking, diabetes mellitus, hyperlipidaemia, obesity, and hypertension, have also been linked with unfavourably altered fibrin clot properties, while some lifestyle modifications and pharmacological treatment, in particular statins and anticoagulants, may improve fibrin structure and function. Prospective studies have suggested that prothrombotic fibrin clot phenotype can predict cardiovascular events in short- and long-term follow-ups. Mutations and splice variants of the fibrinogen molecule that have been proved to be associated with thrombophilia or increased cardiovascular risk, along with fibrinogen post-translational modifications, prothrombotic state, inflammation, platelet activation, and neutrophil extracellular traps formation, contribute also to prothrombotic fibrin clot phenotype. Moreover, about 500 clot-bound proteins have been identified within plasma fibrin clots, including fibronectin, α2-antiplasmin, factor XIII, complement component C3, and histidine-rich glycoprotein. This review summarizes the current knowledge on the mechanisms underlying unfavourable fibrin clot properties and their implications in CVD and its thrombo-embolic manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesBrain IschemiaStrokeThrombosisHypertensionHumansFibrinProspective StudiesFibrinogen

Stichwörter der Autor:innen

Cardiovascular diseaseFibrin clotFibrinolysisThrombosis

Substanzen

FibrinFibrinogen

Autor:innen und Institutionen

  • Thromboembolic Disorders Department, Institute of Cardiology, Jagiellonian University Medical College, 80 Pradnicka St, 31-202 Krakow, Poland.
  • Krakow Center for Medical Research and Technologies, John Paul II Hospital, Krakow, Poland.
  • Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

ORCID-Profile: Michał Ząbczyk, Robert A S Ariëns, Anetta Undas

Förderung

  • British Heart Foundation
  • Jagiellonian University Medical College

Zitieren

APA

Ząbczyk, M., Ariëns, R. A. S., & Undas, A. (2023). Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovascular Research, 119(1), 94-111. https://doi.org/10.1093/cvr/cvad017

Vancouver

Ząbczyk M, Ariëns RAS, Undas A. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovascular Research. 2023;119(1):94-111. doi:10.1093/cvr/cvad017

BibTeX
@article{Zbczyk2023,
  author = {Ząbczyk, Michał and Ariëns, Robert A S and Undas, Anetta},
  title = {Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {1},
  pages = {94--111},
  doi = {10.1093/cvr/cvad017}
}
Kostenlos starten →